If you want to have a better performance than the crowd, you must do things differently from the crowd.
- Value Investor (Sir John Templeton)
Amid the bear market that is hitting bioscience stocks lately, we strongly believe that investors should increase their research due diligence and hunt for promising investments that are on sales substantially below their intrinsic value. Exelixis (NASDAQ:EXEL) is one of the five-star companies of Integrated BioSci Investing that we recommended investors to purchase for their portfolio as they wait for the aforesaid stock to rebound to a new